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Abstract
Background: Sebaceous carcinoma of the breast is a distinct variant of invasive ductal carcinoma. It is rare and
only several cases have been reported.
Case presentation: An 80-year-old woman noted bloody discharge from her left nipple and palpated a lump in her
left breast. Ultrasonography revealed a 19-mm mass in the left breast. Fine-needle aspiration suggested invasive ductal
carcinoma. Partial mastectomy and sentinel lymph node biopsy were performed. On histological examination, the tumor
revealed solid growth of small, round uniform cells with clear cytoplasm, partially intermingled with vacuolated cells
indicative of sebaceous differentiation. The tumor cells contained abundant Sudan Black B-positive lipid droplets in the
cytoplasm, and they were immunohistochemically positive for adipophilin. They were negative for estrogen receptor,
progesterone receptor, and androgen receptor; positive for cytokeratin 7 and Ber-EP4; and partially positive for epithelial
membrane antigen. Based on these findings, the patient was diagnosed with sebaceous carcinoma of the breast.
Conclusions: We diagnosed a rare case of sebaceous carcinoma of the breast.
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Background
Sebaceous carcinoma is a malignant epithelial tumor
derived from or mimicking the sebaceous glands. It is
usually found in the eyelid tumor or skin adnexal
tumor [1, 2], whereas sebaceous carcinoma of the
breast is quite rare and only several cases have been
described. We report a rare case of sebaceous carcin-
oma of the breast and review the immunopathological
findings of the cases reported previously.
Case presentation
An 80-year-old woman noticed bloody discharge from
her left nipple and palpated a lump in her left breast,
and was referred to our hospital. Her mother had a
history of breast cancer. Physical examination revealed a
hard and immovable mass without skin adhesion in the
upper lateral quadrant of the left breast. Cytologically,
no malignant cells were found in the bloody discharge
from the nipple. Laboratory data on admission were
within normal limits. There was no elevation in serum
levels of any tumor marker including CEA, CA15-3,
NCC-ST-439, ICT, and CA19-9. Mammogram showed a
focal asymmetry in the left CC-O (Fig. 1a) and left
MLO-M area (Fig. 1b). Ultrasonography revealed a
hypoechoic mass measuring 19 × 17 × 11 mm with an
irregular margin, acoustic enhancement, and interrup-
tion of the posterior border of the mammary gland in
the upper lateral quadrant of the left breast. It was
connected to the surrounding mammary ducts (Fig. 2).
The mammogram and ultrasonography were classified
into the Breast Imaging Reporting and Data System
(BI-RADS) 5th edition category 3 and 4, respectively.
Contrast-enhanced magnetic resonance imaging (MRI)
confirmed a mass with early enhancement. The mass
had a relatively high intensity, and a peritumoral low-
intensity capsule-like signal was noted on T2-
weighted images (Fig. 3a). MRI also showed early
arterial enhancement, gradual washout, and two
lengths of linear enhancement between the mass and
nipple (Figs. 3b, c). Core needle biopsy of the lesion
demonstrated a solid, proliferating, and invasive
tumor with adipose tissue involvement. These findings
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Fig. 1 a, b Mammogram shows a focal asymmetry in the left CC-O (a) and left MLO-M area (b) (arrows)
Fig. 2 Ultrasonography shows a hypoechoic mass measuring 19 × 17 × 11 mm with an irregular margin, acoustic enhancement, and interruption of the
posterior border of the mammary gland in the upper lateral quadrant of the left breast. It has connections with the surrounding mammary ducts (arrows)
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suggested invasive ductal carcinoma. The tumor was
negative for estrogen receptor (ER) (Fig. 4b), proges-
terone receptor (PgR) (Fig. 4c), and HER2/neu
(Fig. 4d). Positron emission tomography-computed
tomography (PET-CT) revealed the breast tumor with
a maximum standardized uptake value of 4.4 and also
showed a 55-mm mass in the cervix uteri (Fig. 5a, b).
Biopsy from the latter finally confirmed a diagnosis of
cervical carcinoma. After radiotherapy for the cervical
carcinoma, the patient underwent partial mastectomy
and sentinel lymph node biopsy. She was not treated
with neoadjuvant chemotherapy for her triple-negative
Fig. 3 a Magnetic resonance imaging (MRI) shows that the mass has a relatively high intensity and has a peritumoral low-intensity capsule-like
signal on T2-weighted images. b, c Contrast-enhanced MRI shows a mass with early arterial enhancement and two areas of linear enhancement
between the mass and nipple (arrows). d Maximum intensity projection (MIP)
Fig. 4 Microscopic findings on core needle biopsy. a Core needle biopsy suggests invasive ductal carcinoma (HE stain). b–d Tumor cells do not
express estrogen receptor (ER) (b), progesterone receptor (PgR) (c), or HER2/neu protein (d)
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breast carcinoma due to her great age and advanced
cervical carcinoma.
Macroscopically, the breast mass measured 35 mm
in its greatest diameter and had no connection to
the overlying skin or nipple (Fig. 6a). Histologically,
the tumor revealed solid growth of small, round
uniform cells with clear cytoplasm. In part, aggre-
gates of large tumor cells with clear and vacuolated
cytoplasm, indicative of sebaceous differentiation,
were seen (Fig. 6b, c). The intraductal spread of the
tumor was observed with bleeding in dilated ducts.
A part of tumor nodule was surrounded by the
fibrous tissue. No metastatic deposits were identified
in the axillary lymph nodes. On frozen sections,
most part of the tumor cells contained abundant
Sudan Black B-positive lipid droplets in the
cytoplasm (Fig. 6d). Immunohistochemically, 90% of
the cells were positive for adipophilin (Fig. 6e). The
cells were negative for ER, PgR, Her2/neu, and
androgen receptor (AR); positive for cytokeratin 7
and Ber-EP4; and partially positive for epithelial
membrane antigen (EMA). In addition, the tumor
cells were negative for the neuroendocrine markers
such as synaptophysin and chromogranin A. There-
fore, the present case was diagnosed with sebaceous
carcinoma of the breast. She had no complications
of surgery and was discharged from the hospital on
post-operative day 7.
Sixteen months after her breast surgery, the patient
was admitted to the palliative care unit of another
hospital due to her metastatic cervical carcinoma.
There have been no signs of recurrence of breast
malignancy.
Conclusions
Sebaceous carcinoma of the breast is a distinct variant of
invasive ductal carcinoma, characterized by a lobular or
nested growth pattern of tumor cells variably admixed
with cells displaying sebaceous differentiation [3]. Ac-
cording to the World Health Organization histological
classification of tumors of the breast, the definition of
the sebaceous carcinoma of the breast is that a primary
breast carcinoma of the skin adnexal type with seba-
ceous differentiation at least 50% of cells and there
should be no evidence of derivation from cutaneous
adnexal sebaceous glands [4]. The present case fulfilled
the necessary condition.
Pathological diagnosis of sebaceous carcinoma of
the breast is considered to be difficult when
sebaceous differentiation is morphologically obscure.
In such cases, it is necessary to show intracytoplasmic
lipid by Oil Red O or Sudan Black B stain, or to
demonstrate expression of adipophilin by immunohis-
tochemistry. However, lipids are extracted during the
organic phase of tissue processing and lipid staining
cannot be performed in formalin-fixed paraffin-
embedded material. Accordingly, lipid staining can
vividly demonstrate intracytoplasmic lipid only when
fresh frozen material is available [5]. In the present
case, intracytoplasmic lipids were identified through
Sudan Black B and the tumor cells were immunohis-
tochemically positive for adipophilin.
Sebaceous carcinoma should be differentiated from
other rare types of breast carcinoma composed of
vacuolated or clear cells, such as glycogen-rich
carcinoma and lipid-rich carcinoma. Glycogen-rich
carcinoma can be differentiated easily from seba-
ceous carcinoma by lack of lipids in the cytoplasm
of neoplastic cell. Moreover, neoplastic cells of
glycogen-rich carcinoma have a water-clear cyto-
plasm at light microscopy level, whereas sebaceous
carcinoma is composed of vacuolated or foamy cells
[6, 7]. Regarding lipid-rich carcinoma, at least 90%
of tumor cells have abundant clear or vacuolated
lipid-rich cytoplasm [8]. Sebaceous carcinoma shows
a compact lobulated solid growth pattern and finely
Fig. 5 a, b Whole body fluorodeoxyglucose (FDG) positron emission
tomography-computed tomography (PET-CT) images. PET-CT shows
a mass in the left breast with a maximum standardized uptake value
of 4.4 (yellow arrows). b It also shows a nodular lesion in the cervix
uteri, with high FDG uptake (blue arrow)
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vacuolated cells. In contrast, lipid-rich carcinoma in-
filtrates like conventional ductal carcinoma and the
vacuolization is much less conspicuous.
There is no specific imaging finding that are useful
in diagnosis of sebaceous carcinoma of the breast. In
MRI of the present case, linear enhancement between
mass and nipple and capsule-like signal were ob-
served. The linear enhancement indicates intraductal
spread of the tumor. It was identified pathologically
with bleeding in dilated ducts that caused bloody
discharge from her nipple. The capsule-like signal was
pathologically consistent with the fibrous tissue
surrounding the tumor nodule. However, they are not
specific for sebaceous carcinoma.
The number of previously reported cases of seba-
ceous carcinoma of the breast is limited, and their
clinical and pathological features are available in 12
cases (Table 1) [9–17]. According to the reported
cases including ours, 12 patients were women with
ages ranging from 25 to 80 years. ER, PgR, and
HER2/neu showed positivity in 7 of 12, 8 of 12, and
3 of 9 cases, respectively. Although some hormones
or the HER2/neu oncogene may have some role in
the development of sebaceous carcinoma, the details
are unknown.
It has been reported that sebaceous carcinoma of
the breast might be high-grade malignant neoplasm
because three of four patients had axillary lymph
node metastases and two patients experienced an
aggressive clinical course with distant metastases [17].
On the other hand, seven eighths of the cases whose
prognoses were available was alive with or without
evidence of breast malignancy after operation. The
clinical course is not generally known due to its rarity.
Fig. 6 Pathological findings of the resected specimen. a Macroscopically, the tumor, measuring 35 mm in its greatest diameter, has no
connection to the overlying skin or nipple. b The tumor shows solid growth of nests of various sizes in fibrous stroma. c The lesion consists of
dense proliferation of relatively small, round cells and partially intermingled with cells with clear cytoplasm, indicating sebaceous differentiation
(HE stain). d The tumor cells contain abundant Sudan Black B-positive lipid droplets in the cytoplasm. e On immunohistochemistry, 90% of the
cells are positive for adipophilin
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Further study is warranted to elucidate the pathology and
prognosis of the patients with sebaceous carcinoma of the
breast.
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